Amlodipine And Valsartan
Product Images NDC 50090-2471

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amlodipine And Valsartan (NDC 50090-2471). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Probability Of Achieving Systolic Blood Pressure <140 Mmhg At Week 8 (Amlodipine Valsartan 01)

Figure 1: Probability Of Achieving Systolic Blood Pressure <140 Mmhg At Week 8 (Amlodipine Valsartan 01)
This is a graph that shows the effects of different medications on blood pressure. The medications include Amlo/Val 10/320 mg, Valsartan 320 mg, Amlodipine 10 mg, and Placebo. The x-axis shows the baseline systolic blood pressure (SBP) in mmHg, which ranges from 140 to 180. The y-axis shows the different medications. There is a note at the top that says "SBP <140 mmHg", which indicates that the goal is to lower blood pressure to below 140 mmHg.*
FDA Label Image

Figure 2: Probability Of Achieving Diastolic Blood Pressure &lt;90 Mmhg At Week 8 (Amlodipine Valsartan 02)

Figure 2: Probability Of Achieving Diastolic Blood Pressure &lt;90 Mmhg At Week 8 (Amlodipine Valsartan 02)
This text appears to be a chart showing blood pressure readings and medications. It includes readings for diastolic blood pressure (DBP) of less than 90 mmHg and names of medications including AmioNal, Valsartan, Amlodipine, and Placebo. There is also a baseline DBP recorded.*
FDA Label Image

Figure 3: Probability Of Achieving Systolic Blood Pressure &lt;130 Mmhg At Week 8 (Amlodipine Valsartan 03)

Figure 3: Probability Of Achieving Systolic Blood Pressure &lt;130 Mmhg At Week 8 (Amlodipine Valsartan 03)
The text is showing a table of medications and their dosages along with a baseline systolic blood pressure (SBP) measurement in mmHg. The text also highlights a target SBP of less than 130 mmHg. Therefore, it could be useful for evaluating the efficacy of these medications in managing blood pressure.*
FDA Label Image

Figure 4: Probability Of Achieving Diastolic Blood Pressure &lt;80 Mmhg At Week 8 (Amlodipine Valsartan 04)

Figure 4: Probability Of Achieving Diastolic Blood Pressure &lt;80 Mmhg At Week 8 (Amlodipine Valsartan 04)
This document includes information on blood pressure readings and medication dosages. It appears to include a comparison of two medications (Amio/Val and Valsartan) as well as a placebo, with dosages given for Amlodipine, and baseline DBP readings listed at the bottom.*
FDA Label Image

Amlodipine Besylate Structural Formula (Amlodipine Valsartan 05)

FDA Label Image

Valsartan Structural Formula (Amlodipine Valsartan 06)

FDA Label Image

Label Image (Lbl500902471)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.